The analysis of GBM database (GBM Bio-DP) revealed that low mRNA levels of all four genes (NG2, PDGFRA, PDGFRB, and ITGB1) in MES, PN, and NE subtypes are associated with an increased patient survival. The gene discussed is PDGFRA; the disease is glioblastoma.